Results 71 to 80 of about 226,558 (238)

Forest plot comparison (Vaginal P compared with no treatment or placebo) for outcome: Neonatal respiratory distress syndrome (RDS).

, 2023
CI, confidence interval; Vaginal P, vaginal progesterone. (TIF)
Silvia Minozzi (5914076), Francesca Ferrari (5018804), Laura Basile (14664703), Fabio Facchinetti (3166995), Giuseppe Chiossi (5432516)   +4 more
core   +1 more source

Vaginal delivery of progesterone in donor oocyte therapy [PDF]

Human Reproduction, 2000
A prospective cohort study, with 345 women requiring complete progesterone replacement for a donor egg cycle, was used to compare Crinone 8% (90 mg progesterone vaginal gel) twice or once daily versus i.m. progesterone (100 mg), for endometrial development and pregnancy support.
openaire   +2 more sources

Ovarian Cancer: Epidemiology, Disease Mechanisms, New Diagnosis and Treatment Strategies, and Research Directions

iNew Medicine, EarlyView.
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid, Weirong Fan, Farah Nazir, Yixiang Xing, Tengchuan Jin   +4 more
wiley   +1 more source

Forest plot comparison (Vaginal P compared with no treatment or placebo) for outcome: Low birth weight.

, 2023
CI, confidence interval; Vaginal P, vaginal progesterone; SD, Standard deviation. (TIF)
Silvia Minozzi (5914076), Francesca Ferrari (5018804), Laura Basile (14664703), Fabio Facchinetti (3166995), Giuseppe Chiossi (5432516)   +4 more
core   +1 more source

Characterization of Crinone®: Progesterone Vaginal Gel

International Journal of Pharmaceutics
Crinone®, a progesterone-containing vaginal gel, is prescribed in clinical practice for hormone replacement therapy and assisted reproductive technology. Despite its clinical significance, limited studies have delved into its physicochemical properties and release behavior.
Ji Li, Kaikai Wang, Ziyi Lu, Yiran Huo, Vivian Juang, Antonela Rodriguez, Anna Schwendeman   +6 more
openaire   +2 more sources

Personalized multimodal physiological modeling of menstrual cycle dynamics using endocrine, metabolic and wearable signals

Journal of Intelligent Medicine, EarlyView.
Abstract Menstrual cycle tracking remains challenged by the limited physiological scope and inconsistent generalizability of existing wearable‐based approaches, which often rely on individual sensing modalities that incompletely capture the complexity of menstrual physiology.
Ejay Nsugbe, Georgianna Lin
wiley   +1 more source

Forest plot comparison (Vaginal P compared with no treatment or placebo) for outcome: Admission in neonatal intensive care unit (NICU).

, 2023
CI, confidence interval; Vaginal P, vaginal progesterone. (TIF)
Silvia Minozzi (5914076), Francesca Ferrari (5018804), Laura Basile (14664703), Fabio Facchinetti (3166995), Giuseppe Chiossi (5432516)   +4 more
core   +1 more source

Combination of cervical cerclage and vaginal progesterone for prevention of preterm birth in singleton pregnancy with a short cervix: a scoping review

Journal of Pharmacy Practice and Research, EarlyView.
Abstract Background Women with a short cervix are at increased risk of preterm birth (PTB), a major contributor to neonatal morbidity and mortality globally, leading to significant financial and emotional burdens for families and healthcare systems.
Sarah Amin Abou‐El‐Makarem, Mohamed Shaaban   +1 more
wiley   +1 more source

Comparison of the efficacy of subcutaneous versus vaginal progesterone using a rescue protocol in vitrified blastocyst transfer cycles

, 2023
Research question: Does administration of subcutaneous (s.c.) progesterone support ongoing pregnancy rates (OPR) similar to vaginal progesterone using a rescue protocol in hormone replacement therapy frozen embryo transfer cycles?
Erden, Murat, Hakan Yarali, Murat Erden, Irem Yarali Ozbek, MÜMÜŞOĞLU, SEZCAN, Polat, Mehtap, Sandro C. Esteves, Peter Humaidan, YARALI, HAKAN, Mehtap Polat, Humaidan, Peter, Ozbek, Irem Yarali, Sezcan Mumusoglu, Esteves, Sandro C.   +13 more
core   +1 more source

Luteal phase support in assisted reproductive technology treatment: focus on Endometrin® (progesterone) vaginal insert

Therapeutics and Clinical Risk Management, 2009
Jerome H CheckThe University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital/University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility,
Jerome H Check
doaj